Rentschler Biopharma SE, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), appointed Günter Stempfer site head of the company’s facility in Laupheim, Germany.  He will report to chief operating officer Christiane Bardroff. In his new role, Stempfer will head the site leadership team in Laupheim and will be part of the global leadership team. Stempfer is responsible for continuously identifying opportunit...